aod9604 6mg Growth Hormone Fragment Peptide AOD-9604 (5mg) – Nordsci
Description
The SURMOUNT-1 trial demonstrated 20.9% mean body weight reduction with tirzepatide 15mg weekly at 72 weeks, while preclinical 5-amino-1MQ studies showed visceral fat reduction independent of caloric restriction

"Low plasma antioxidants and normal plasma B vitamins and homocysteine in patients with severe obesity"

Measuring your AOD 9604 dose With 2ml of bac water in a 5mg vial (2500mcg/ml concentration), here are common doses in insulin syringe units

Preclinical studies in rodents have demonstrated reductions in fat mass, improved insulin sensitivity, and increased metabolic rate without significant changes to food intake (Neelakantan et al., 2019)

Some people who do not get enough B12 naturally in their diet
